PMID: 6112292Apr 18, 1981Paper

Menopausal oestrogen therapy and protection from death from ischaemic heart disease

Lancet
R K RossB E Henderson

Abstract

The medical records of a Los Angeles retirement community were examined to find out the association between oestrogen replacement therapy and death from ischaemic heart disease. Women dying from ischaemic heart disease over a five-year period were compared with living and deceased control groups; both controls were matched with cases for date of birth, date of entry into the community, race, and socioeconomic status. The deceased control was also matched for date of death. Compared with living controls cases using conjugated oestrogens had a risk ratio for death from ischaemic heart disease of 0.43 (95% confidence interval 0.24-0.75). Comparison with deceased controls gave a similar relative risk. This association was not due to identifiable confounding factors. Other risk factors for ischaemic heart disease, including hypertension, diabetes, stroke, angina pectoris, and heavy cigarette smoking, were confirmed by this study.

References

Jun 3, 1976·The New England Journal of Medicine·L RosenbergH Jick
Jun 3, 1976·The New England Journal of Medicine·T M MackS E Brown

❮ Previous
Next ❯

Citations

Oct 1, 1990·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·C Christiansen, R Lindsay
Jan 1, 1993·Archives of Gynecology and Obstetrics·R Lindgren
May 2, 2003·Current Hypertension Reports·J Michael Wyss, Scott H Carlson
Sep 1, 1991·Atherosclerosis·M Seed
Dec 28, 1992·European Journal of Obstetrics, Gynecology, and Reproductive Biology·R LindgrenA G Olsson
Mar 1, 1995·European Journal of Obstetrics, Gynecology, and Reproductive Biology·C SchubringG Müller-Berghaus
Feb 1, 1994·European Journal of Obstetrics, Gynecology, and Reproductive Biology·S H RavnE Bostofte
Feb 1, 1996·Obstetrics and Gynecology·J M Sullivan, L P Fowlkes
Oct 12, 1991·Lancet
Jan 1, 1983·Social Science & Medicine·I Waldron
Sep 1, 1995·European Journal of Obstetrics, Gynecology, and Reproductive Biology·M HabibaF al-Azzawi
Jun 1, 1996·European Journal of Obstetrics, Gynecology, and Reproductive Biology·M HabibaF al-Azzawi
Mar 1, 1984·Maturitas·L CardozoD J Cooper
May 1, 1996·Maturitas·R PunnonenP Laippala
May 1, 1994·Experimental Gerontology·S M McKinlay
Dec 1, 1989·American Journal of Obstetrics and Gynecology·M Notelovitz
Jan 15, 2002·European Journal of Obstetrics, Gynecology, and Reproductive Biology·D PanidisK Stergiopoulos
Feb 1, 1997·European Journal of Obstetrics, Gynecology, and Reproductive Biology·A Jakab
Jun 8, 2001·Maturitas·A R Genazzani, M Gambacciani
Dec 4, 2001·Maturitas·M Gambacciani, A R Genazzani
Jul 29, 1999·Maturitas·A R Genazzani, M Gambacciani
Jan 15, 2000·Journal of the American College of Cardiology·J M GazianoJ E Buring
Jan 1, 1993·Baillière's Clinical Endocrinology and Metabolism·A Green, C Bain
Aug 1, 1987·Baillière's Clinical Endocrinology and Metabolism·A H Kissebah, G Schectman
Oct 27, 2001·International Journal of Dermatology·E Aizen, A Gilhar
Dec 31, 1981·The New England Journal of Medicine·M I WhiteheadR J King
Jun 10, 1982·The New England Journal of Medicine
Oct 24, 1985·The New England Journal of Medicine·M J StampferC H Hennekens
Jun 19, 1986·The New England Journal of Medicine·R J ChetkowskiH L Judd
Oct 9, 1986·The New England Journal of Medicine·M L PadwickM I Whitehead

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.